Effect of GIP and GLP-1 antagonists on insulin release in the rat

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 6 39-6, 1999, Pages

  Tseng, Chi Chuan ^a   Zhang, Xiao Ying ^a   Wolfe, M Michael ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Exendin; Glucagon; Glucose tolerance test; Glucose dependent insulinotropic polypeptide antagonist

Indexed keywords

EXENDIN[9 39] AMIDE; GLUCAGON LIKE PEPTIDE 1; HORMONE ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; INHIBITION KINETICS; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; SMALL INTESTINE;

EID: 0033037273     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.6.e1049     Document Type: Article

References (31)

1. Bergmeyer, H. U., E. Bernt, F. Schmidt, and H. Stork. Methods of Enzymatic Analysis, 1974, p. 1196-1201.
2. Brubaker, P. L. Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. Endocrinology 128: 3175-3182, 1991.
3. Cataland, S., S. E. Crockett, J. C. Brown, E. L. Mazzaferri. Gastric inhibitory polypeptide stimulation by oral glucose in man. J. Clin. Endocrinol. Metab. 39: 223-228, 1974.
4. Cheeseman, C. I., and R. Tseng. The effect of GIP and GLP-1 on intestinal basolateral membrane hexose transport. Am. J. Physiol. 271 (Gastrointest. Liver Physiol. 34): G477-G482, 1996.
5. Cheeseman, C. I., and R. Tseng. The effect of GIP and GLP-1 on intestinal basolateral membrane hexose transport. Am. J. Physiol. 271 (Gastrointest. Liver Physiol. 34): G477-G482, 1996.
6. Creutzfeldt, W. Frontiers of hormone research. In: Gut Regulatory Peptides: Their Role in Health and Disease, edited by E. Blazquez. Basel: Karger, 1987, vol. 16, p. 1-14.
7. Creutzfeldt, W., and M. A. Nauck. Gut hormones and diabetes mellitus. Diabetes Metab. Rev. 8: 149-177, 1992.
8. D'Alessio, D. A., R. L. Prigeon, and J. W. Ensinck. Enternal enhancement of glucose disposition by both insulin-dependent and insulin-independent process. A physiological role of GLP-1. Diabetes 44: 1433-1437, 1995.
9. Damholt, A. B., A. M. J. Buchan, and H. Kofod. GLP-1 secretion from canine L-cells is increased by GIP peptide but unaffected by glucose. Endocrinology 139: 2085-2091, 1998.
10. Dupre, J., S. A. Ross, D. Watson, and J. C. Brown. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J. Clin. Endocrinol. Metab. 37: 826-828, 1973.
11. Elliott, R. M., L. M. Morgan, J. A. Tredger, S. Deacon, J. Wright, and V. Marks. Glucagon-like peptide-1 (7-37) amide and glucose-dependent insulinotropic polypeptide in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J. Endocrinol. 138: 159-166, 1993.
12. Fehmann, H., R. Goke, and B. Goke. Cell and molecular biology of the incretin hormones GLP-1 and GIP. Endocrinology 16: 390-410, 1995.
13. Herrmann, C., R. Goke, G. Richter, H. C. Fehmann, R. Arnold, B. Goke. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56: 117-126, 1995.
14. Herrmann-Rinke, C., A. Voge, M. Hess, and B. Goke. Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides. J. Endocrinol. 147: 25-31, 1995.
15. Hirsh, A. J., S. Y. M. Yao, J. D. Young, and C. I. Cheeseman. Inhibition of glucose absorption in the rat jejunum: a novel action of α-D-glucosidase inhibitors. Gastroenterology 113: 205-211, 1997.
16. Holst, J. J., C. Orskov, O. V. Nielsen, and T. W. Schwartz. Truncated glucagon-like peptide I, an insulin releasing hormone from the distal gut. FEBS Lett. 211: 169-174, 1987.
17. Kerymann, B., G. Williams, M. A. Ghatei, and S. R. Bloom. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2: 1300-1304, 1987.
18. Kolligs, F., H. C. Fehmann, R. Goke, and B. Goke. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. Diabetes 44: 16-19, 1995.
19. Mojsov, S., G. C. Weir, and J. F. Habener. Insulinotropin: glucagon-like peptide (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79: 616-619, 1987.
20. Moore, B., E. S. Edie, and J. H. Abram. On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochem. J. 1: 28-38, 1906.
21. Nauck, M., E. Bartles, C. Orskov, R. Ebert, and W. Creutzfeldt. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and GLP-1 infused at near-physiological insulinotropic hormone and glucose concentrations. J. Clin. Endocrinol. Metab. 76: 912-917, 1993.
22. Nauck, M. A., W. E. Schmidt, R. Ebert, J. Strietzel, P. Cantor, G. Hoffmann, and W. Creutzfeldt. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8. J. Clin. Endocrinol. Metab. 69: 654-662, 1989.
23. Ørskov, C., L. Rabenhoj, A. Wettergren, H. Kofod, and J. J. Holst. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide in humans. Diabetes 43: 535-539, 1994.
24. Pederson, R. A. Gastric inhibitory polypeptide. In: Gut Peptides: Biochemistry and Physiology, edited by J. H. Walsh and G. J. Dockray. New York: Raven, 1994, p. 217-259.
25. Pederson, R. A., M. Satkunarajah, C. H. S. McIntosh, L. A. Scrocchi, D. Flamez, F. Schuit, D. J. Drucker, and M. B. Wheeler. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/-mice. Diabetes 47: 1046-1052, 1998.
26. Pederson, R. A., H. E. Schubert, and J. C. Brown. Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog. Diabetes 24: 1050-1056, 1975.
27. Thomas, F. B., D. Sinar, E. L. Mazzaferri, S. Cataland, H. S. Mekhjian, J. H. Caldwell, and J. J. Fromkes. Selective release of gastric inhibitory polypeptide release by intraduodenal amino acid perfusion in man. Gastroenterology 74: 1261-1265, 1978.
28. Tseng, C. C., T. J. Kieffer, L. A. Jarboe, T. B. Usdin, and M. M. Wolfe. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide. J. Clin. Invest. 98: 2440-2445, 1996.
29. Usdin, T. B., E. Mezey, D. C. Button, M. J. Brownstein, and T. I. Bonner. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133: 2861-2870, 1993.
30. Wang, Z., R. M. Wang, A. A. Owji, D. M. Smith, M. A. Ghatei, and S. R. Bloom. Glucagon-like peptide-1 is a physiological incretin in rat. J. Clin. Invest. 95: 417-421, 1995.
31. Zunz, E., And J. La Barre. Contributions a l'etude des variations physiologiques de la seretion interne du pancreas: relations entre les seretions externe et interne du pancreas. Arch. Int. Physiol. Biochim. Biophys. 31: 20-44, 1929.